Radiohalogens for imaging and therapy
- 21 December 2004
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 34 (2), 153-163
- https://doi.org/10.1039/b313872k
Abstract
Radiohalogens play a very important role in radiopharmaceuticals used for medical imaging (now referred to as molecular imaging) and therapy applications. Development of new radiopharmaceuticals that have radiohalogens incorporated requires an understanding of parameters that are unique to chemistry involving these radionuclides. Those parameters include requirement for production and purification of the halogen radionuclides, as well as development of reaction conditions for use with high specific activity short-lived radionuclides. In this tutorial review, several radiohalogens, their radiolabeling chemistry and their application to medical imaging and therapy are discussed.Keywords
This publication has 21 references indexed in Scilit:
- Radiohalogen incorporation into organic systemsJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Radiohalogenated carbohydrates for use in PET and SPECTJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Comparison of fluorine-18 and bromine-76 imaging in positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Catalytic effect of copper(II) chloride on the radioiodination of L-p-iodophenylalanineJournal of Labelled Compounds and Radiopharmaceuticals, 1997
- Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a reviewApplied Radiation and Isotopes, 1994
- Regioselective radiofluorodestannylation with [18F]F2 and [18F]CH3COOF: A high yield synthesis of 6-[18F]fluoro-l-dopaInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992
- Synthesis of L-6-[123I]iodo-m-tyrosine a potential spect brain imaging agentJournal of Labelled Compounds and Radiopharmaceuticals, 1990
- Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediateInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- Labeling of a serotoninergic ligand with 18F : [18F] setoperoneJournal of Labelled Compounds and Radiopharmaceuticals, 1988